These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 27704357

  • 1. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
    Lin L, Wang G, Ming J, Meng X, Han B, Sun B, Cai J, Jiang C.
    Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
    [Abstract] [Full Text] [Related]

  • 2. Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
    Li Q, Chen B, Cai J, Sun Y, Wang G, Li Y, Li R, Feng Y, Han B, Li J, Tian Y, Yi L, Jiang C.
    PLoS One; 2016 Nov; 11(3):e0151815. PubMed ID: 27022952
    [Abstract] [Full Text] [Related]

  • 3. TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas.
    Chen C, Han S, Meng L, Li Z, Zhang X, Wu A.
    PLoS One; 2014 Nov; 9(6):e100297. PubMed ID: 24937153
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
    Li MY, Yang P, Liu YW, Zhang CB, Wang KY, Wang YY, Yao K, Zhang W, Qiu XG, Li WB, Peng XX, Wang YZ, Jiang T.
    Sci Rep; 2016 Feb 16; 6():21141. PubMed ID: 26879272
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA-584-3p, a novel tumor suppressor and prognostic marker, reduces the migration and invasion of human glioma cells by targeting hypoxia-induced ROCK1.
    Xue H, Guo X, Han X, Yan S, Zhang J, Xu S, Li T, Guo X, Zhang P, Gao X, Liu Q, Li G.
    Oncotarget; 2016 Jan 26; 7(4):4785-805. PubMed ID: 26715733
    [Abstract] [Full Text] [Related]

  • 11. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S, Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, Oka S, Noshiro S, Akiyama Y, Mikami T, Mikuni N, Kocsis JD, Honmou O.
    J Neurosurg; 2017 Feb 26; 126(2):467-475. PubMed ID: 27081897
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
    Huang RQ, Shi DL, Huang W, Chen F, Lu YC.
    J Neurooncol; 2016 Apr 26; 127(2):235-42. PubMed ID: 26725095
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Predictive molecular pathological testing in the diagnosis of high-grade tumors of glial origin].
    Molnár P, Méhes G.
    Magy Onkol; 2009 Mar 26; 53(1):33-8. PubMed ID: 19318324
    [Abstract] [Full Text] [Related]

  • 15. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
    Hagemann C, Fuchs S, Monoranu CM, Herrmann P, Smith J, Hohmann T, Grabiec U, Kessler AF, Dehghani F, Löhr M, Ernestus RI, Vince GH, Stein U.
    Neuro Oncol; 2013 Dec 26; 15(12):1696-709. PubMed ID: 24220141
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.
    Metellus P, Nanni-Metellus I, Delfino C, Colin C, Tchogandjian A, Coulibaly B, Fina F, Loundou A, Barrie M, Chinot O, Ouafik L, Figarella-Branger D.
    Ann Surg Oncol; 2011 Oct 26; 18(10):2937-45. PubMed ID: 21479688
    [Abstract] [Full Text] [Related]

  • 17. Characterization of a side population of astrocytoma cells in response to temozolomide.
    Chua C, Zaiden N, Chong KH, See SJ, Wong MC, Ang BT, Tang C.
    J Neurosurg; 2008 Nov 26; 109(5):856-66. PubMed ID: 18976075
    [Abstract] [Full Text] [Related]

  • 18. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G, Skiriutė D, Kazlauskas A, Golubickaitė I, Stakaitis R, Tamašauskas A, Vaitkienė P.
    Diagn Pathol; 2016 Apr 27; 11():42. PubMed ID: 27121858
    [Abstract] [Full Text] [Related]

  • 19. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S, Sugita Y, Miyoshi H, Arakawa F, Muta H, Ishibashi Y, Niino D, Ohshima K, Terasaki M, Nakamura Y, Morioka M.
    J Neurooncol; 2016 Mar 27; 127(1):23-32. PubMed ID: 26645886
    [Abstract] [Full Text] [Related]

  • 20. Stem cell markers in glioma progression and recurrence.
    Hattermann K, Flüh C, Engel D, Mehdorn HM, Synowitz M, Mentlein R, Held-Feindt J.
    Int J Oncol; 2016 Nov 27; 49(5):1899-1910. PubMed ID: 27600094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.